Open tender · Germany · Pharmaceutical products
Open house Arzneimittelrabattverträge Eltrombopag, ausgeschl. Anwendungsgebiet schwere aplastische Anämie in der Fachinformation, es sei denn, der Hersteller genießt hierfür Patenschutz, ATC B02BX05
In EnglishOpen house drug discount contracts for Eltrombopag, excluded indication severe aplastic anemia in the product information, unless the manufacturer has patent protection for this indication, ATC B02BX05
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open house drug discount contracts for Eltrombopag, excluded indication severe aplastic anemia in the product information, unless the manufacturer…”. Bids close on 3 August 2027, 12:00 CEST. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Non-exclusive discount agreements for Eltrombopag (ATC B02BX05), excluding severe aplastic anemia.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 0 requirements to qualify and the 3 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences
